11. PWE-082 Audit of Barrett's Oesophagus Surveillance in The London Cancer Alliance – Structured Programmes with Dedicated Lists/Databases Improve Prague Scoring and Appropriate Follow Up Intervals. (17th August 2016) Authors: Dunn, JM; Wilson, P; Chatu, S; Collins, C; Gess, M; Hayat, JO; Haycock, A; Hoare, J; Hunt, J; Lean, S; Pee, L; Walker, G; Zar, S; Hanna, G Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. PWE-131 Endoscopically treatable t1 oesophageal adenocarcinoma diagnosed by emr – what is the value of ct, pet and eus?. (17th June 2017) Authors: Rusu, R; Zeki, S; DeMartino, S; Nasr, I; Chang, F; Meenan, J; Dunn, JM Journal: Gut Issue: Volume 66(2017)Supplement 2 Page Start: A193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. PWE-186 Use of dna ploidy in routine pathology practice as a biomarker for barrett's oesophagus with high risk clinical features. (22nd June 2015) Authors: Dunn, JM; Chang, F; Novelli, M; Odell, EW Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A293 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. PWE-354 Can we safely carry out less intensive colonoscopy surveillance in patients post curative colorectal cancer resection?. (22nd June 2015) Authors: Johnston, EL; Zacks, A; Shaheen, S; Ataklte, F; George, M; Dunn, JM Journal: Gut Issue: Volume 64(2015)Supplement 1 Page Start: A366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗